Award
National Cancer Institute 5R01CA285967-02
Targeting heat shock factor 1 (HSF1) to increase tumor infiltrating lymphocytes in metastatic breast cancer.
Recipient
National Cancer Institute (NCI), part of the National Institutes of Health (NIH)
Award Amount
$375,964.00
Ceiling
$375,964.00
Awarded
April 27, 2026
Identifier
5R01CA285967-02
Research project by NIH/NCI to study HSF1's role in immune cell recruitment and treatment efficacy in metastatic breast cancer.
Description
This is a research project funded by the NIH/NCI focusing on immunotherapy and metastatic breast cancer. The project involves multiple aims including studying the role of HSF1 in immune cell recruitment, assessing the efficacy of HSF1 inhibition, and understanding myeloid cell populations in breast tumors.